Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agents

Clinical Microbiology and Infection

Volumn 22, Issue 5, 2016, Pages 462.e1-462.e3

  Pavone, P ^a   Tieghi, T ^b   d'Ettorre, G ^a   Lichtner, M ^a,b   Marocco, R ^b   Mezzaroma, I ^a   Passavanti, G ^a   Vittozzi, P ^a   Mastroianni, C M ^a,b   Vullo, V ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cirrhosis; DAAs; Diabetes; HCV; HIV HCV

Indexed keywords

ANTIDIABETIC AGENT; ANTIVIRUS AGENT; DACLATASVIR; DASABUVIR PLUS OMBITASVIR PLUS PARITAPREVIR PLUS RITONAVIR; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LEDIPASVIR PLUS SOFOSBUVIR; METFORMIN; OMBITASVIR PLUS PARITAPREVIR PLUS RITONAVIR; REPAGLINIDE; RIBAVIRIN; SIMEPREVIR; SOFOSBUVIR; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; DIABETIC PATIENT; FEMALE; GLYCEMIC CONTROL; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 1; HEPATITIS C VIRUS GENOTYPE 2; HEPATITIS C VIRUS GENOTYPE 3; HEPATITIS C VIRUS GENOTYPE 4; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT MONITORING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; COMPLICATION; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; HEPATITIS C, CHRONIC; ITALY; MIDDLE AGED;

ADULT; AGED; ANTIVIRAL AGENTS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; ROME;

EID: 84961813396     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2015.12.030     Document Type: Article

References (6)

1. Del Campo J.A., García-Valdecasas M., Rojas L., Rojas Á., Romero-Gómez M. The hepatitis C virus modulates insulin signaling pathway in vitro promoting insulin resistance. PLoS One 2012, 7:e47904.
2. Delgado-Borrego A., Liu Y.S., Jordan S.H., Agrawal S., Zhang H., Christofi M., et al. Prospective study of liver transplant recipients with HCV infection: evidence for a causal relationship between HCV and insulin resistance. Liver Transpl 2008, 14:193-201.
3. Naing C., Mak J.W., Ahmed S.I., Maung M. Relationship between hepatitis C virus infection and type 2 diabetes mellitus: meta-analysis. World J Gastroenterol 2012, 18:1642-1651.
4. Ruhl C.E., Menke A., Cowie C.C., Everhart J.E. Relationship of hepatitis C virus infection with diabetes in the US population. Hepatology 2014, 60:1139-1149.
5. Soriano V., Barreiro P., de Mendoza C. Hypoglycemia in a diabetic patient during hepatitis C therapy. Hepatology 2016, In press.
6. García-Compeán D., González-González J.A., Lavalle-González F.J., González-Moreno E.I., Villarreal-Pérez J.Z., Maldonado-Garza H.J. Current concepts in diabetes mellitus and chronic liver disease: clinical outcomes, hepatitis C virus association, and therapy. Dig Dis Sci 2016, In press.